In 2016, the AACR reported another year of positive financial growth. This financial stability enables the AACR to comprehensively meet the challenges of the cancer problem and respond to today’s exciting research opportunities. Operating revenues increased 10 percent to $87 million and total expenditures closely matched revenues. The net impact of revenues and expenses resulted in an operating surplus of $1.6 million. As outlined in this report, several major projects were launched in 2016, and the AACR was able to outperform the budget through successful programs, revenue growth, evaluation of expenses, and prudent financial management.

Non-operating activities are primarily related to long-term investments. The AACR’s investments provided strong returns in the amount of $3.5 million in a year of stock market volatility and economic uncertainty.

The results of the combined operating and non-operating activities resulted in a net surplus of $5.1 million, which enabled the AACR’s unrestricted net assets to grow to $60.5 million. This important source of income ensures continued investment in the programs that will accelerate progress toward the prevention and cure of cancer in accordance with AACR’s strategic plan.